|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/197 | |
| A61K 33/26 | |||
| A61P 31/16 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2875813 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13819512.8 |
| Europos patento paraiškos padavimo data | 2013-06-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/003486 |
| Data | 2013-06-03 |
| (87) | Numeris | WO 2014/013664 |
| Data | 2014-01-23 |
| (30) | Numeris | Data | Šalis |
| 2012160999 | 2012-07-19 | JP |
| (72) |
TANAKA, Tohru, JP
NAKAJIMA, Motowo, JP
TAKAHASHI, Kiwamu, JP
ISHII, Takuya, JP
KIDO, Hiroshi, JP
CHIDA, Junji, JP
YAMANE, Kazuhiko, JP
|
| (73) |
SBI Pharmaceuticals Co., Ltd.,
6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020,
JP
Tokushima University, 24, Shinkura-cho 2-chome Tokushima-shi, Tokushima 770-8501, JP |
| (54) | PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION |
| PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION |